Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2022-04-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
关于益丰大药房连锁股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Regulatory Filings
2022-04-28 Chinese
益丰药房高级管理人员集中竞价减持股份时间届满暨减持结果公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the completion of a share reduction plan by senior management personnel of the company. It details the number of shares held before and after the reduction, the reduction plan implementation period, and the results of the reduction. It does not contain financial statements or detailed financial performance data. The document is focused on insider share transactions by company executives, specifically the reduction of shares held by senior management. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 2520 characters, which is consistent with an announcement rather than a full report. Hence, the classification is DIRS with high confidence.
2022-04-28 Chinese
益丰药房关于续聘2022年会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (auditor) for the fiscal year 2022. It details the auditor's qualifications, independence, audit fees, and the approval process by the board and audit committee. It does not contain actual financial statements or audit results but rather informs shareholders and the public about the intention to continue using the same audit firm for the upcoming audit. The document length is 3777 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it focuses on audit-related information and auditor appointment, but it is not the full audit report itself nor an annual report. FY 2022
2022-04-28 Chinese
益丰药房2022年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第一季度报告' which translates to '2022 First Quarter Report'. It contains detailed financial statements including balance sheets, profit and loss statements, and cash flow statements for the first quarter of 2022. The document explicitly states it is an unaudited quarterly report and includes comprehensive financial data and analysis for the quarter. This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (over 12,000 characters) and contains actual financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2022
2022-04-28 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the repayment of temporarily used convertible bond funds for working capital. It details the amounts repaid and references previous related announcements. The content focuses on capital usage and repayment, which aligns with updates on company financing activities. The document length is short (806 characters) and it is not a full financial report but a specific update on capital usage. Therefore, it fits best under Capital/Financing Update (CAP).
2022-04-26 Chinese
益丰药房关于召开2021年度业绩暨现金分红说明会的公告.docx
Investor Presentation Classification · 95% confidence The document is an announcement about a scheduled investor meeting to discuss the 2021 annual performance and cash dividend. It specifies the date, time, location, and format of the meeting, and invites investors to participate and ask questions. The document does not contain actual financial statements or detailed financial analysis but rather serves as a notice for an upcoming event where such information will be discussed. The document length is short (1582 characters), and it clearly states that the 2021 annual report will be published on April 29, 2022, indicating this document is a preparatory announcement rather than the report itself. Therefore, this fits the category of an Investor Presentation (IP) or possibly a Report Publication Announcement (RPA). However, since it is about an investor meeting focused on discussing financial results and dividends, and includes details about the meeting format and participation, it aligns best with Investor Presentation (IP).
2022-04-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.